Wieland Capital

Wieland Capital is a family office established in 2004 and located in Munich, Germany. The firm specializes in investing its own resources along with the wealth of its affiliated families in small and medium-sized companies. Wieland Capital primarily targets investment opportunities within the DACH region, which includes Germany, Austria, and Switzerland.

Franck Godet

Partner

Robert Wieland

Founder and Partner

3 past transactions

Noscendo

Venture Round in 2022
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.

Lifespin

Convertible Note in 2021
lifespin GmbH is a data company created to map the human health condition. Our proprietary, highly scalable method allows to digitize quantitatively metabolomes on population level. We created quantitative metabolic digital profiles of more than 130k patients. We have defined the baseline for human health and can show for each patient individual deviations. We are building digital products for providers & patients for the early detection and monitoring of diseases.

Noscendo

Series A in 2020
Noscendo GmbH is a diagnostics company based in Duisburg, Germany, specializing in bioinformatics solutions for identifying and assessing pathogens associated with bloodstream infections. Their diagnostic procedures utilize Next Generation Sequencing (NGS) technology, enabling intensive care clinicians to detect bacteria, fungi, viruses, and parasites present in patients' blood. Noscendo employs proprietary algorithms to evaluate the significance of each identified pathogen, thereby enhancing the accuracy and effectiveness of infection management in clinical settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.